openPR Logo
Press release

Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conjunctivitis Treatment Market

09-04-2018 08:02 PM CET | Health & Medicine

Press release from: Precision Business Insights

Acute Conjunctivitis Treatment Market

Acute Conjunctivitis Treatment Market

Acute Conjunctivitis Treatment Market


Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but treatment can speed up the recovery process. Allergic conjunctivitis can be treated with antihistamines. Bacterial conjunctivitis can be treated with antibiotic eye drops.

Acute Conjunctivitis Treatment Market is growing due to increase of aging population, increase in ophthalmic diseases prevalence rate, rise in investments for the development of new products, growing conscious towards health, funded eye check-up campaigns by governments of different countries are driving the growth of allergic conjunctivitis treatment market. Moreover, increasing awareness about various eye infections and rise in blindness prevalence among geriatric population boosting the growth of allergic conjunctivitis treatment market. However, due to the stringent regulations in drugs developmental process and side effects associated with the various antibiotics would hamper the adoption of eye infection pharmaceutical treatment, in turn, hinder the growth of bacterial conjunctivitis treatment market.

The global acute conjunctivitis treatment market is categorized as-

Type of conjunctivitis
Viral Conjunctivitis
Bacterial Conjunctivitis
Allergic Conjunctivitis
Conjunctivitis Caused by Irritants
Dosage form
Gels and Cream
Eye drops
Tablets and Capsules
Drug class
Antihistamines
Antibiotic
Mast cell stabilizers
Anti-inflammatory drugs
Others
End-users
Hospital, retail and online pharmacies

And finally on the basis of geographical regions, the global acute conjunctivitis treatment market is divided into five major regions-North America, Europe, the Middle East & Africa and Latin America. North America is dominating global bacterial conjunctivitis treatment market owing to few factors like rising more number of approvals by FDA, various strong strategies by pharma companies, rise in R&D investments. The European market is the second largest in allergic conjunctivitis market. Increase in prevalence and growing awareness of conjunctivitis and its treatments are leading the growth of Asia Pacific allergic conjunctivitis treatment market. The Middle East and Africa allergic conjunctivitis market is expected to have limited growth because of lack of traditional healthcare practices and slow adoption of new products and therapies.

Some of the key players in global acute conjunctivitis treatment market are Pfizer, Inc. (U.S), Allergan Inc. (Ireland), Boehringer Ingelheim GmbH (Germany), CIBA Vision Ophthalmics (U.S), Sanofi (France), Novartis AG (Switzerland), Bausch & Lomb Inc. (Valeant) (Canada), Merck & Co., Inc. (U.S), and Santen Pharmaceuticals Co. Ltd.(Japan). For e.g. in 2017, Teva Pharmaceuticals launched, generic version of Pataday (olopatadine hydrochloride ophthalmic solution) 0.2%, in U.S used to treat Allergic conjunctivitis.

As per the clinical study conducted by scientists Neal P. Barney and Amir A. Azari in 2013, which was published in Journal of American Medical Association (JAMA), states that bacterial conjunctivitis accounts for about 50% of conjunctivitis cases in U.S. and also estimated that the bacterial conjunctivitis incidence rate was anticipated as 135 in 10,000.Top pharma companies are dominating the market owing to different factors like sale, strong global presence, and efficient distribution network, R&D investments, products of superior quality, and strong brand image. In 2016, Irish based pharma company Shire’s Xiidra received U.S.FDA approval which is used to treat dry-eye.

For More Information: https://www.precisionbusinessinsights.com/market-reports/global-acute-conjunctivitis-treatment-market/

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conjunctivitis Treatment Market here

News-ID: 1220102 • Views: 856

More Releases from Precision Business Insights

Clinical Trials Market Share, Trends, Competitor Analysis and Forecast to 2019-2 …
Analyst Speak: “The Global Clinical Trials Market is expected to reach US$ 69.1 Bn by 2025 due to growing occurrences of life threatening diseases and technological advancements in the field of drug discovery” The global clinical trials market is expected to reach US$ 69.1 Bn by 2025. Clinical trials are experiments or observations done in clinical research to generate data on safety and efficacy. Clinical trials are done on vaccines, drugs,
Diabetes Care Devices Market is Expected to Reach US$ 24,368.4 Mn by 2025
Analyst Speak: “The Diabetes Care Devices Market is increasing at significant CAGR over the forecast period 2019-2025 and expected to reach US$ 24,368.4 Mn by 2025, due to rise in prevalence of diabetes in various countries around the world”. Precision Business Insights (PBI) in its report titled “Diabetes Care Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period
Carbon Fiber Prepreg Market Opportunities, Size, Share, Key Players, and Regiona …
The Global Carbon Fiber Prepreg Market poised to reach US$ XX Mn by 2025 with a significant CAGR over seven years forecast period 2019-2025 owing to the increasing demand from various industries. Precision Business Insights (PBI) in its report titled “Global Carbon Fiber Prepreg Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025.
Global Insulation Coatings Market Growth, Trends, Analysis, Segmentation, Foreca …
Precision Business Insights (PBI) in its report titled “Global Insulation Coating Material Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Global Insulation Coating Material Market

All 5 Releases


More Releases for Conjunctivitis

Conjunctivitis Market - key players covered:Pfizer, Inc., Novartis, ... Conjunct …
Los Angeles, United State, –The report titled Global Conjunctivitis Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Conjunctivitis market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Conjunctivitis market.
Viral Conjunctivitis Market- Pipeline Review, H1 2020
A new research document is added in HTF MI database of 50 pages, titled as 'Viral Conjunctivitis - Pipeline Review, H1 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions like North America, Europe or Asia and important players/vendors such as Adenovir Pharma AB, Invirsa Inc, IVIEW Therapeutics Inc, NanoViricides Inc, Okogen Inc, Panoptes Pharma GesmbH, Starpharma Holdings Ltd, TGV-Inhalonix Inc. The
Acute Conjunctivitis Treatment Market | Bacterial conjunctivitis | PBIGP
The Future Insights Of Global Acute Conjunctivitis Treatment Market Conjunctivitis, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Conjunctivitis can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but treatment can
Global Conjunctivitis Market 2018 - Allergan.Inc, Merck, Novartis
Apex Market Reports, recently published a detailed market research study focused on the “Conjunctivitis Market” across the global, regional and country level. The report provides 360° analysis of “Conjunctivitis Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Conjunctivitis on the basis of
Viral Conjunctivitis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Viral Conjunctivitis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Viral Conjunctivitis - Pipeline Review, H2 2017, provides an overview of the Viral Conjunctivitis (Ophthalmology) pipeline landscape. Viral conjunctivitis, or pinkeye, is a common, self-limiting condition that is typically caused by adenovirus. Viral conjunctivitis is highly
Allergic Conjunctivitis - Pipeline Review, H2 2016
MarketResearchReports.Biz presents this most up-to-date research on "Allergic Conjunctivitis - Pipeline Review, H2 2016" Description Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Conjunctivitis Pipeline Review, H2 2016, provides an overview of the Allergic Conjunctivitis (Ophthalmology) pipeline landscape. Allergic conjunctivitis occurs when the clear layer of tissue lining the eyelids and covering the white of the eye (conjunctiva) become swollen or inflamed due to a reaction to pollen, dander, mold,